Zak Mir takes a charting perspective to some of the most followed small caps on the London market. Today’s selection includes Argo, Cloudbreak, Cornish, Eurasia, Eve, Kodal, Novacyt, Synairgen, Sound,
Zak Mir takes a charting perspective to some of the most followed small-cap stocks on the London market. Today’s selection includes Atlantic Lithium, Beowulf, Belluscura, Catenae, Equals, Future, Ironveld, Novacyt,
Zak Mir takes a technical perspective on some of the most followed stocks of the day. Today’s selection includes Avacta, BT, Braveheart, EQTEC, i3 Energy, MyHealthChecked, Novacyt, Nanosynth, Rockfire, Sourcebio.
Zak Mir takes a technical perspective on some of the most followed small caps via the charts of the FTSE 100 and Bitcoin. Today’s stocks include Agronomics, Dev Clever, EQTEC,
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Braveheart, Genedrive, MyHealthChecked, Novacyt, Nanosynth, Scancell, Sareum, Synairgen and
Paris, France and Camberley, UK – 26 November 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the announcement on 2
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Brandshield, Galileo, Insig AI, Novacyt, Omega Diagnostics, Pantheon, Red
Zak Mir looks at some of the most followed small caps on the London market. Today’s selection includes Avacta, Braveheart, Chamberlin, Chill, C4X, CyanConnode, Hummingbird, IronRidge, Mode, Net Zero, Novacyt,
Gold producer Caracal Gold (GCAT), updated on operations at its producing Kilimapesa Gold Mining and Processing Operations in Kenya, where it is advancing a phased mine optimisation and expansion strategy.
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Accelr8, Argo, Chaarat, DeepVerge, Eurasia, GSTechnologies, I-nexus, Microsaic, Novacyt,
Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
